EUCTR2022-000338-41-NL进行中（未招募）1 期
Pred Forte® in chronic central serous chorioretinopathy - PICS Trial
Stichting Radboud universitair medisch centrum0 个研究点目标入组 40 人开始时间: 2022年3月28日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- diagnosis of severe chronic central serous chorioretinopathy
- •- 18 years or older and doesn’t meet any exclusion criteria
- •- is willing to sign the consent form
- •- is able to self-administer eye drops.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 40
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- when there is evidence of another retinal diagnoses, such as a history of exudative age-related macular degeneration, suspicion of secondary choroidal neovascularization, polypoidal choroidal vasculopathy, multifocal choroiditis, retinal vascular occlusions, pseudoxanthoma elasticum, amblyopia, and severe myopia (more than -6 dioptres)
- •- woman that are pregnant or breast feeding
研究者
相似试验
招募中
3 期
Pred Forte® in chronic central serous chorioretinopathy10047060CSCcentral serous chorioretinopathyNL-OMON51739Radboud Universitair Medisch Centrum40
已完成
1 期
Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave AcetateChronic Central Serous ChorioretinopathyNCT00489840Manhattan Eye, Ear & Throat Hospital5
已完成
1 期
Topical Interferon Gamma-1b for Central Serous ChorioretinopathyRetinal DiseaseMacular DiseaseNCT01468337National Eye Institute (NEI)5
已完成
2 期
High-dose Antioxidants for Central Serous ChorioretinopathyCentral Serous ChorioretinopathyNCT00963131Prince of Songkla University60
已完成
不适用
Central Serous Chorioretinopathy: Etiology, Course and PrognosisCentral Serous ChorioretinopathyNCT01378130Medical University of Vienna50